Surgery Websites
Transplant Surgery »  Meet the Team »  Hepatology »  Giuseppe Cullaro M.D., M.A.S.
Giuseppe Cullaro M.D., M.A.S

Giuseppe Cullaro M.D., M.A.S

  • Assistant Professor, Medicine
  • Hepatologist

Contact Information

521 Parnassus Avenue, #6229
San Francisco, CA 94117
Phone: 415-476-3143
Orchid: Orchid 0000-0002-2935-0245
Open Popup
  Dept or School    
  End Date    
  • University of California, San Francisco, San Francisco, CA
  • MAS
  • Masters in Clinical Research
  • 06/2019
  • Boston University School of Medicine, Boston, MA
  • MD
  • 05/2013
  • New York Presbyterian—Cornell and Columbia University, New York, NY
  • Advanced/Transplant Hepatology
  • 06/2020
  • New York Presbyterian—Columbia University, New York, NY
  • Internal Medicine Residency
  • 06/2016
  • University of California, San Francisco, San Francisco, CA
  • Gastroenterology Fellowship
  • 06/2019
  • Boston University, Boston, MA
  • BS
  • Biochemistry and Molecular Biology
  • 05/2009
  • I am a gastroenterologist and transplant hepatologist who cares for patients with general hepatology and transplant hepatology needs.

    My academic interests lie at the intersection of hepatology and nephrology. Specifically, I focus on improving outcomes for patients with end-stage liver disease by identifying predictive markers of future kidney dysfunction—markers that may inform the mechanism of disease pathogenesis and allow for the implementation of preventative strategies.

    I earned my undergraduate and medical degrees from Boston University. I completed a residency in Internal Medicine at New York Presbyterian—Columbia University, followed by a gastroenterology fellowship at UCSF, and a transplant hepatology fellowship at New York Presbyterian—Cornell and Columbia University in 2020. I obtained a Master of Advanced Studies in Clinical Research through the UCSF Graduate Division in 2019.
      Confired By    
  • AASLD Early Career Investigator Award in Clinical/Translational Science
  • American Association For The Study Of Liver Disease
  • 2019
  • AASLD Foundation Advanced/Transplant Hepatology Award
  • American Association For The Study Of Liver Disease
  • 2019
  • Young Investigator Award
  • American Transplant Congress
  • 2019
  • GI Jeopardy Champion
  • American College of Gastroenterology
  • 2017
  • House Staff Teaching Award
  • New York Presbyterian—Columbia University
  • 2015
  • Alpha Omega Alpha
  • Boston University School of Medicine
  • 2013
  • Data provided by UCSF Profiles, powered by CTSI
    ORCID iD: 0000-0002-2935-0245 Additional info
    • Novel Biomarkers to Identify Advanced Kidney Dysfunction Among Outpatients with Cirrhosis
      Sponsor ID:
      Funding Period:
      Jul 2019
      Jul 2021
    Data provided by UCSF Profiles, powered by CTSI
    Data provided by UCSF Profiles, powered by CTSI
    1. Cullaro G, Ge J, Lee BP, Lai JC, Wadhwani SI. Association between neighborhood-based material deprivation and liver transplant waitlist registrants demographics and mortality. Clin Transplant. 2023 Nov 08; e15189. View in PubMed
    2. Lai M, Fenton C, Ge J, Rubin J, Lai JC, Cullaro G. Nonselective beta-blockers may lead to stage 2 acute kidney injury and waitlist mortality in child class C cirrhosis. Hepatol Commun. 2023 10 01; 7(10). View in PubMed
    3. Patidar KR, Cullaro G, Naved MA, Kabir S, Grama A, Orman ES, Piano S, Allegretti AS. Prognostic significance of acute kidney injury stage 1B in hospitalized patients with cirrhosis: A US nationwide study. Liver Transpl. 2023 Aug 09. View in PubMed
    4. Wang M, Ge J, Ha N, Shui AM, Huang CY, Cullaro G, Lai JC. Clinical Characteristics Associated With Posttransplant Survival Among Adults 70 Years Old or Older Undergoing Liver Transplantation. J Clin Gastroenterol. 2023 Jun 07. View in PubMed
    5. Cullaro G. Reply: Variability in serum creatinine is associated with waitlist and post-liver transplant mortality in patients with cirrhosis. Hepatology. 2023 08 01; 78(2):E35-E36. View in PubMed
    6. View All Publications


    Site Directory